Prognostic analysis of interim 18F-FDG PET/CT in patients with diffuse large B cell lymphoma after one cycle versus two cycles of chemotherapy.

Ling YuanMichael C KreisslLiping SuZhifang WuMarcus HackerJianzhong LiuXi ZhangYunfeng BoHongyu ZhangXiang LiSijin Li

Published in: European journal of nuclear medicine and molecular imaging (2018)

Interim 18F-FDG PET/CT after one cycle of chemotherapy is feasible and yields similar predictive results as compared to an interim 18F-FDG PET/CT after two cycles of chemotherapy in patients suffering from DLBCL. The combination of interim 18F-FDG PET/CT with the MYC gene diagnosis might provide increased prognostic value for DLBCL.

Keyphrases

diffuse large b cell lymphoma
epstein barr virus
locally advanced
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
genome wide
squamous cell carcinoma
rectal cancer
transcription factor
copy number
radiation therapy
chemotherapy induced